Anti-mitotic agent and aurora kinase inhibitor combination as anti-cancer treatment

Details for Australian Patent Application No. 2008282885 (hide)

Owner SCHERING CORPORATION

Inventors Basso, Andrea Dawn

Agent Griffith Hack

Pub. Number AU-A-2008282885

PCT Pub. Number WO2009/017701

Priority 60/953,087 31.07.07 US; 61/023,985 28.01.08 US

Filing date 28 July 2008

Wipo publication date 5 February 2009

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/4365 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

25 February 2010 PCT application entered the National Phase

  PCT publication WO2009/017701 Priority application(s): WO2009/017701

9 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008282886-Content publishing systems and methods

2008282876-Vectors and methods for cloning gene clusters or portions thereof